Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Talpaz

Showing results (111-120 of 350) with videos related to

Pageof 35
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1991
Phase I study of recombinant human interleukin-3 in patients with bone marrow failureR Kurzrock, M Talpaz, Z Estrov, et al.
Human Pathology|May 1, 1997
Physiology and pathophysiology of dendritic cellsV Wright-Browne, K L McClain, M Talpaz, et al.
Annals of Internal Medicine|April 1, 1991
Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia. Philadelphia chromosome-positive patientsM Talpaz, H Kantarjian, R Kurzrock, et al.
The Journal of Clinical Investigation|October 1, 1994
Persistence of dormant leukemic progenitors during interferon-induced remission in chronic myelogenous leukemia. Analysis by polymerase chain reaction of individual coloniesM Talpaz, Z Estrov, H Kantarjian, et al.
The American Journal of Medicine|January 1, 1997
Clinical correlates of elevated serum levels of interleukin 6 in patients with untreated Hodgkin's diseaseJ F Seymour, M Talpaz, F B Hagemeister, et al.
Cancer|October 24, 2000
Therapeutic choices in younger patients with chronic myelogenous leukemiaH M Kantarjian, F J Giles, S O'Brien, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2002
Quantitative measurement of BCR/abl transcripts using real-time polymerase chain reactionW I Lee, H Kantarjian, A Glassman, et al.
Leukemia|June 25, 1998
GM-CSF can improve the cytogenetic response obtained with interferon-alpha therapy in patients with chronic myelogenous leukemiaJ Cortes, H Kantarjian, S O'Brien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1986
Clinical toxicity of interferons in cancer patients: a reviewJ R Quesada, M Talpaz, A Rios, et al.
Leukemia Research|June 1, 1997
Suppressed formation of bone marrow adherent layers derived from acute myeloid leukemia patients after in vitro exposure to interleukin-4M Wetzler, R Kurzrock, Z Estrov, et al.
Pageof 35

Showing results (111-120 of 350) with videos related to

Sort By:
Pageof 35
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1991
Phase I study of recombinant human interleukin-3 in patients with bone marrow failureR Kurzrock, M Talpaz, Z Estrov, et al.
Human Pathology|May 1, 1997
Physiology and pathophysiology of dendritic cellsV Wright-Browne, K L McClain, M Talpaz, et al.
Annals of Internal Medicine|April 1, 1991
Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia. Philadelphia chromosome-positive patientsM Talpaz, H Kantarjian, R Kurzrock, et al.
The Journal of Clinical Investigation|October 1, 1994
Persistence of dormant leukemic progenitors during interferon-induced remission in chronic myelogenous leukemia. Analysis by polymerase chain reaction of individual coloniesM Talpaz, Z Estrov, H Kantarjian, et al.
The American Journal of Medicine|January 1, 1997
Clinical correlates of elevated serum levels of interleukin 6 in patients with untreated Hodgkin's diseaseJ F Seymour, M Talpaz, F B Hagemeister, et al.
Cancer|October 24, 2000
Therapeutic choices in younger patients with chronic myelogenous leukemiaH M Kantarjian, F J Giles, S O'Brien, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2002
Quantitative measurement of BCR/abl transcripts using real-time polymerase chain reactionW I Lee, H Kantarjian, A Glassman, et al.
Leukemia|June 25, 1998
GM-CSF can improve the cytogenetic response obtained with interferon-alpha therapy in patients with chronic myelogenous leukemiaJ Cortes, H Kantarjian, S O'Brien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1986
Clinical toxicity of interferons in cancer patients: a reviewJ R Quesada, M Talpaz, A Rios, et al.
Leukemia Research|June 1, 1997
Suppressed formation of bone marrow adherent layers derived from acute myeloid leukemia patients after in vitro exposure to interleukin-4M Wetzler, R Kurzrock, Z Estrov, et al.
Pageof 35